Witryna26 mar 2024 · L’herceptin ® est aussi appelée trastuzumab. Cet anticorps a été découvert dans les années 80 par le docteur Salomon. Il est utilisé dans le traitement … Witryna1 lip 2024 · HERCEPTINE : indication secondaire. La seule indication secondaire de l’herceptine est le cancer gastrique métastatique (adénocarcinome métastatique). …
Haute Autorité de Santé - PHESGO (pertuzumab, trastuzumab)
WitrynaTrastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for cancer that is HER2 receptor positive. It may … WitrynaTrastuzumab, sold under the brand name Herceptin among others, is a monoclonal antibody used to treat breast cancer and stomach cancer. It is specifically used for … aruba 9004 initial setup
Herceptin SC (Subcutaneous Trastuzumab - Northern Cancer …
WitrynaGrade 1 or 2, continue Herceptin SC treatment Grade 3 or 4, hold Herceptin SC treatment until recovery to ≤ Grade 2 If the patient misses a dose of Herceptin SC, … WitrynaHerceptin often causes side effects, although many of these will become less severe over time. The following side effects are experienced by around 1 in 10 people: a reaction to the medicine, such as chills, a high temperature, swelling of the face and lips, headache, hot flushes, feeling sick, wheezing and breathlessness. WitrynaHerceptin alone is approved for the treatment of HER2-positive breast cancer in patients who have received one or more chemotherapy courses for metastatic disease. As … aruba 9240 (us) campus gateway